Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (371-380 of 544) with videos related to

Pageof 55
Sort By:
Breast Cancer Research : BCR|December 7, 2007
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenWilliam D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, et al.
Cancers|November 26, 2020
Breast Cancer Mortality among Women with a <i>BRCA1</i> or <i>BRCA2</i> Mutation in a Magnetic Resonance Imaging Plus Mammography Screening ProgramEllen Warner, Siqi Zhu, Donald B Plewes, et al.
International Journal of Cancer|January 14, 2015
CHEK2 mutations and the risk of papillary thyroid cancerMonika Siołek, Cezary Cybulski, Danuta Gąsior-Perczak, et al.
Familial Cancer|August 29, 2009
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30Ophira M Ginsburg, Mohammad R Akbari, Zeba Aziz, et al.
Breast Cancer Research and Treatment|March 5, 2013
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysisEileen Rakovitch, Sharon Nofech-Mozes, Steven A Narod, et al.
Breast Cancer Research and Treatment|January 19, 2016
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control studyJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Genes|July 29, 2023
The <i>APOBEC3B</i> c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish PopulationKatarzyna Gliniewicz, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Henry T Lynch, et al.
Cancer|October 10, 2003
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinomaWilliam D Foulkes, Kelly Metcalfe, Wedad Hanna, et al.
Breast Cancer Research and Treatment|May 17, 2008
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an updateOphira Ginsburg, Parviz Ghadirian, Jan Lubinski, et al.
Pageof 55

Showing results (371-380 of 544) with videos related to

Sort By:
Pageof 55
Breast Cancer Research : BCR|December 7, 2007
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenWilliam D Foulkes, Parviz Ghadirian, Mohammed Reza Akbari, et al.
Cancers|November 26, 2020
Breast Cancer Mortality among Women with a <i>BRCA1</i> or <i>BRCA2</i> Mutation in a Magnetic Resonance Imaging Plus Mammography Screening ProgramEllen Warner, Siqi Zhu, Donald B Plewes, et al.
International Journal of Cancer|January 14, 2015
CHEK2 mutations and the risk of papillary thyroid cancerMonika Siołek, Cezary Cybulski, Danuta Gąsior-Perczak, et al.
Familial Cancer|August 29, 2009
The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30Ophira M Ginsburg, Mohammad R Akbari, Zeba Aziz, et al.
Breast Cancer Research and Treatment|March 5, 2013
Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysisEileen Rakovitch, Sharon Nofech-Mozes, Steven A Narod, et al.
Breast Cancer Research and Treatment|January 19, 2016
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control studyJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Genes|July 29, 2023
The <i>APOBEC3B</i> c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish PopulationKatarzyna Gliniewicz, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupTimothy R Rebbeck, Tara Friebel, Henry T Lynch, et al.
Cancer|October 10, 2003
Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinomaWilliam D Foulkes, Kelly Metcalfe, Wedad Hanna, et al.
Breast Cancer Research and Treatment|May 17, 2008
Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an updateOphira Ginsburg, Parviz Ghadirian, Jan Lubinski, et al.
Pageof 55